HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC.
Saved in:
| Title: | HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC. |
|---|---|
| Authors: | Mei, Jie1 (AUTHOR), Jiang, Guanyu2 (AUTHOR), Chen, Yundi3 (AUTHOR), Xu, Yongrui2 (AUTHOR), Wan, Yuan3 (AUTHOR), Chen, Ruo2 (AUTHOR), Liu, Feng2 (AUTHOR), Mao, Wenjun2 (AUTHOR) maowenjun1@njmu.edu.cn, Zheng, Mingfeng2 (AUTHOR) zhengmfmedical@126.com, Xu, Junying1 (AUTHOR) doctorxyj123@163.com |
| Source: | BMC Cancer. 7/6/2022, Vol. 22 Issue 1, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-022-09840-6 |
